Mixed Analyst Signals on Defense Funding Reinforce WAIT Stance

What happened

Lockheed Martin shares rose on October 14 despite Bernstein cutting its price target on worries about defense funding in Congress. Vertical Research analyst Robert Stallard countered that funding for Patriot missiles appears secure. The stock's pop suggests the market is leaning on the bullish demand narrative for missile defense. Our DeepValue report already identifies PAC-3 funding as the critical near-term catalyst and a key risk to the thesis. The mixed analyst views do not change our assessment that LMT is fairly valued at $582.6, trading at 21.4x earnings.

Implication

Investors should not chase the stock on analyst noise. The Bernstein target cut highlights the appropriations risk we flagged, while Vertical Research's Patriot optimism underscores the demand narrative. Our base case remains dependent on funded PAC-3 awards and MFC margin staying above 14%. Until those are confirmed, the current valuation offers limited margin of safety. We maintain a WAIT rating with a trim level above $650 and an attractive entry around $545.

Thesis delta

No material shift. The news is consistent with our thesis that missile demand is robust but funding timing and execution remain key risks. Our rating and fair value estimates are unchanged.